Literature DB >> 18281452

Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes.

B Carlander, T Vincent, A Le Floch, N Pageot, W Camu, Y Dauvilliers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18281452     DOI： 10.1136/jnnp.2007.135228

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.

Authors:  Toru Baba; Ichiro Nakashima; Takashi Kanbayashi; Masatoshi Konno; Toshiyuki Takahashi; Kazuo Fujihara; Tatsuro Misu; Atsushi Takeda; Yusei Shiga; Hiromasa Ogawa; Yasuto Itoyama
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

2.  Anhidrosis associated with hypothalamic lesions related to anti-aquaporin 4 autoantibody.

Authors:  Teruhiko Sekiguchi; Satoru Ishibashi; Takayuki Kubodera; Junya Fukabori; Akihito Uezato; Takashi Kanbayashi; Toshiyuki Takahashi; Takanori Yokota; Hidehiro Mizusawa
Journal:  J Neurol       Date:  2011-06-03       Impact factor: 4.849

3.  Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.

Authors:  Romain Marignier; Pascale Giraudon; Sandra Vukusic; Christian Confavreux; Jérôme Honnorat
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

4.  A case with anti-galactocerebroside antibody-positive Mycoplasma pneumoniae meningoencephalitis presenting secondary hypersomnia.

Authors:  Naoto Sugeno; Norihiko Kawaguchi; Takafumi Hasegawa; Takashi Kuroda; Ichiro Nakashima; Takashi Kanbayashi; Susumu Kusunoki; Masashi Aoki
Journal:  Neurol Sci       Date:  2012-03-15       Impact factor: 3.307

5.  IgG abnormality in narcolepsy and idiopathic hypersomnia.

Authors:  Susumu Tanaka; Makoto Honda
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

6.  Symptomatic Narcolepsy as a Presenting Feature of Neuromyelitis Optica.

Authors:  Pradeep Kallollimath; Amruth Gujjar; Megharanjini Patil
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.